The pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has posed serious threats to global health and economy, thus calling for the development of safe and effective vaccines. The receptor-binding domain (RBD) in the spike protein of SARS-CoV-2 is responsible for its binding to angiotensin-converting enzyme 2 (ACE2) receptor. It contains multiple dominant neutralizing epitopes and serves as an important antigen for the development of COVID-19 vaccines. Here, we showed that immunization of mice with a candidate subunit vaccine consisting of SARS-CoV-2 RBD and Fc fragment of human IgG, as an immunopotentiator, elicited high titer of RBD-specific antibodies with robust neutralizing activity against both pseudotyped and live SARS-CoV-2 infections. The mouse antisera could also effectively neutralize infection by pseudotyped SARS-CoV-2 with several natural mutations in RBD and the IgG extracted from the mouse antisera could also show neutralization against pseudotyped SARS-CoV and SARS-related coronavirus (SARSr-CoV). Vaccination of human ACE2 transgenic mice with RBD-Fc could effectively protect mice from the SARS-CoV-2 challenge. These results suggest that SARS-CoV-2 RBD-Fc has good potential to be further developed as an effective and broad-spectrum vaccine to prevent infection of the current SARS-CoV-2 and its mutants, as well as future emerging SARSr-CoVs and re-emerging SARS-CoV.
【저자키워드】 Vaccines, Infection, 【초록키워드】 COVID-19, coronavirus disease, SARS-CoV-2, IgG, Coronavirus disease 2019, ACE2, Vaccine, coronavirus, pandemic, SARS-CoV, neutralization, threat, Economy, severe acute respiratory syndrome Coronavirus, angiotensin-converting enzyme 2, immunization, Spike protein, global health, Antigen, human ACE2, Epitopes, Neutralizing activity, COVID-19 vaccines, Health, infections, Receptor-binding domain, neutralizing epitope, mice, RBD, mutants, Subunit vaccine, receptor, respiratory, SARS-CoV-2 infections, Antisera, specific antibodies, binding, Angiotensin-converting enzyme, angiotensin, Safe, Immunopotentiator, SARS-CoV-2 RBD, fragment of, natural mutations, Fc fragment, natural mutation, SARSr-CoV, acute respiratory syndrome, subunit, acute respiratory syndrome coronavirus, acute respiratory syndrome coronavirus 2, domain, Effective vaccines, CoVs, transgenic mice, live SARS-CoV-2, RBD-specific antibodies, pseudotyped, pseudotyped SARS-CoV-2, RBD-Fc, SARS-related coronavirus, SARSr-CoVs, dominant, Prevent, effective, neutralize, robust, PROTECT, responsible, caused, the spike protein, elicited, RBD-specific antibody, the SARS-CoV-2, 【제목키워드】 COVID-19 vaccine, SARS-CoV-2 neutralizing antibody, induce,